Adults aged ≥26 years are not routinely recommended to receive HPV vaccine.
However, some adults may benefit from HPV vaccination. When deciding whether to vaccinate adults, consider:
the likelihood of previous exposure to HPV
the future risks of HPV exposure
Many adults are likely to have been exposed to 1 or more HPV types contained in the vaccine through sexual activity (see Epidemiology). Vaccination will not clear a past infection, but can provide protection against future infections.
The recommended schedule for adults aged ≥26 years is 3 doses, with an interval of 2 months between dose 1 and dose 2, and 4 months between dose 2 and dose 3.
